An increasing focus on biologics, genomics, and multi-omics; the adoption of digital technologies; and a shift to patient-centric models are transforming the life sciences industry. At the same time, the emergence of value-based models, R&D activities to treat complex diseases, and healthcare consumerism provide an impetus to precision medicine.
• In addition, the COVID-19 pandemic has underscored the need for equanimity in access to diagnostics.
• It also renewed focus on direct-to-patient, decentralized diagnostics products as well as digital continuity, all of which center the patient.
• Frost & Sullivan identifies the 10 top growth opportunities for the global life sciences and diagnostics industry in 2023.
Sign up for a complimentary Growth Pipeline Dialog™
A Growth Pipeline Dialog is a structured open discussion with our growth experts providing unparalleled industry intelligence, technology advancements, and proven implementation best practices. This discussion will spark innovative thinking and help generate a pipeline of growth opportunities you can leverage to maximize your company’s future growth potential.
